Equasens Shares Dip 2% Midday After a Monthly High of €40.45
Fueled by an unusually strong upward momentum in recent days, the tech stock Equasens begins a consolidation movement this Thursday morning. Trading around €38.10 at mid-session, the stock is down 2.06% from its previous close of €38.90, amidst a tense European market environment. This correction follows the stock reaching its highest level in a month at €40.45 earlier in the week.
Equasens has shown a weekly performance of 12.39%, significantly exceeding the usual fluctuations observed in the stock. This abnormal progression brought the stock close to €40.45, marking a monthly peak. Since this peak, the ongoing session's pullback has brought the price below the technical resistance identified at €40.10, a level that has not been sustainably exceeded. Technically, the stock remains above its 50-day moving average, set at €36.77, indicating a favorable short-term dynamic despite today's correction. The RSI, at 63, suggests a tense situation but does not yet reach the clear overbought zone. The one-month volatility remains high, at 10.82%, consistent with the magnitude of recent movements. No specific fundamental catalyst has been identified to explain last week's movement.
April 2 Session in a Tense International Market Environment
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The trading session on April 2 takes place in a tense international stock market environment. The verbal escalation between Washington and Tehran, which has been sending mixed signals about a possible ceasefire in Iran, contributes to significant volatility across all markets. The VIX index, although down from the previous day at 25.25 points compared to 30.61, remains at a level indicating high tension. In this context, the declines observed in leading European tech sector stocks illustrate the prevailing caution. Equasens' performance over the past year remains positive at 10.92%, but the trajectory over the last three months, at -15.33%, reminds us that the journey has been turbulent. On the agenda, investors will be watching for the publication of the first quarter 2026 revenue, expected on April 29.
SectorLogiciels et services numériques›Logiciels et données de santé (healthtech)
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 181,8 millions d'euros
Quarterly revenue: 181,8 millions d'euros
Revenue growth: 5,6 %
Guidance from the release
« Sur les neuf premiers mois de l'année, le Groupe affiche une bonne performance. [...] Avec la montée en puissance du Ségur Vague 2 au quatrième trimestre, nous restons pleinement mobilisés pour renforcer notre dynamique commerciale d'ici la fin d'année et préparer les relais de croissance de 2027. »
Risks mentioned
Environnement plus exigeant pour les Divisions E-CONNECT et MEDICAL SOLUTIONS
Division E-CONNECT face à tensions sur les chaînes d'approvisionnement et fluctuations de prix de composants
Contexte de taux de financement élevés et volatils affectant la Division FINTECH
Opportunities identified
Montée en puissance du programme Ségur Vague 2 au T4 2026 dans les Divisions AXIGATE LINK et MEDICAL SOLUTIONS
Intégration de l'Intelligence Artificielle au cœur des logiciels métier et stratégie de commercialisation SaaS en Europe
Forte dynamique du secteur Hôpital (+81,8% sur 9 mois) avec référencements Ségur obtenus pour déploiements T4 2026
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.